Travere Therapeutics Inc. (TVTX)
NASDAQ · Healthcare
Travere Therapeutics Inc. Total Liabilities 2011–2025
Travere Therapeutics Inc. annual total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Travere Therapeutics Inc. total liabilities as of December 31, 2025: 490.4M, a 8.35% decrease year-over-year.
- Travere Therapeutics Inc. total liabilities for 2025 were 490.4M, a 8.35% decrease from 2024.
- Travere Therapeutics Inc. total liabilities for 2024 were 535.0M, a 9.02% decrease from 2023.
- Travere Therapeutics Inc. total liabilities for 2023 were 588.1M, a 6.61% decrease from 2022.
- Travere Therapeutics Inc. total liabilities for 2022 were 629.7M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Travere Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $490 |
| 2024 | $535 |
| 2023 | $588 |
| 2022 | $630 |
| 2021 | $475 |
| 2020 | $396 |
| 2019 | $384 |
| 2018 | $391 |
| 2017 | $227 |
| 2016 | $218 |
Travere Therapeutics Inc. Total Liabilities — FAQ
Travere Therapeutics Inc. (TVTX) total liabilities over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TVTX's total liabilities history?
The chart and table above show Travere Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.